Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases.

Saved in:
Bibliographic Details
Title: Efficacy and Prognostic Factors for Y-90 Radioembolization (Y-90) in Metastatic Neuroendocrine Tumors with Liver Metastases.
Authors: Tsang ES; Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada., Loree JM; Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada., Davies JM; Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada., Gill S; Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada., Liu D; Department of Radiology, Vancouver General Hospital, Vancouver, BC, Canada., Ho S; Department of Radiology, Vancouver General Hospital, Vancouver, BC, Canada., Renouf DJ; Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada., Lim HJ; Division of Medical Oncology, BC Cancer, Vancouver, BC, Canada., Kennecke HF; Floyd and Delores Jones Cancer Institute, Virginia Mason Cancer Institute, Seattle, WA, USA.
Source: Canadian journal of gastroenterology & hepatology [Can J Gastroenterol Hepatol] 2020 Nov 23; Vol. 2020, pp. 5104082. Date of Electronic Publication: 2020 Nov 23 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: Hindawi Publishing Corporation Country of Publication: Egypt NLM ID: 101623613 Publication Model: eCollection Cited Medium: Internet ISSN: 2291-2797 (Electronic) Linking ISSN: 22912789 NLM ISO Abbreviation: Can J Gastroenterol Hepatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2291-2797
DOI:10.1155/2020/5104082